Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Amortizatization of Intangibles (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Amortizatization of Intangibles data on record, last reported at -$6.0 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles changed N/A year-over-year to -$6.0 million; the TTM value through Dec 2025 reached $13.0 million, changed N/A, while the annual FY2025 figure was $13.0 million, 48.0% down from the prior year.
  • Amortizatization of Intangibles reached -$6.0 million in Q4 2025 per RCUS's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $11.0 million in Q2 2024 and bottomed at -$6.0 million in Q4 2025.
  • Average Amortizatization of Intangibles over 5 years is $2.1 million, with a median of $2.0 million recorded in 2022.
  • The widest YoY moves for Amortizatization of Intangibles: up 1259.39% in 2021, down 1189.39% in 2021.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $1.3 million in 2021, then soared by 669.82% to $10.0 million in 2022, then tumbled by 80.0% to $2.0 million in 2023, then soared by 200.0% to $6.0 million in 2024, then plummeted by 200.0% to -$6.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$6.0 million in Q4 2025, $2.0 million in Q1 2025, and $6.0 million in Q3 2024.